Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric Mycoplasma pneumoniae pneumonia: a real-world evidence study.

Saved in:
Bibliographic Details
Title: Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric Mycoplasma pneumoniae pneumonia: a real-world evidence study.
Authors: Deng J; Department of Pharmacy, The First Hospital of Jilin University, Changchun, China., Li Y; Department of Pediatrics, The First Hospital of Jilin University, Changchun, China., Liu C; School of Pharmaceutical Sciences, Jilin University, Changchun, China., Qu X; Department of Pharmacy, The First Hospital of Jilin University, Changchun, China., Song Y; Department of Pharmacy, The First Hospital of Jilin University, Changchun, China.; School of Pharmaceutical Sciences, Jilin University, Changchun, China.
Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2026 Feb 13; Vol. 16, pp. 1782840. Date of Electronic Publication: 2026 Feb 13 (Print Publication: 2026).
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2235-2988
DOI:10.3389/fcimb.2026.1782840